Switch to
More onapp

How to use scorecard? Learn more

EVOQ Remedies Ltd

EVOQ
Trading
SmallcapWith a market cap of ₹15 cr, stock is ranked 3,921
High RiskStock is 7.53x as volatile as Nifty
10.001.14 (-10.23%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

High

Strong financials and growth story over the years

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Trading
SmallcapWith a market cap of ₹15 cr, stock is ranked 3,921
High RiskStock is 7.53x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
PB RatioPB Ratio
0.61
Dividend YieldDiv. Yield
Sector PESector PE
-50.87
Sector PBSector PB
0.99
Sector Div YldSctr Div Yld
0.25%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

EVOQ Remedies Limited is engaged in the pharmaceutical business. The Company is engaged in marketing, trading, and distribution of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic and anti-cold drugs, analgesic/ antipyretic and anti-inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastrointestinal drugs, steroids, gynecology drugs, calcium, multivitamins, antioxidants, and injections. The Company also deals in the trading of active pharmaceutical ingredients (APIs). The Company's products include Abacavir Sulphate, Acetazolamide, Acyclovir, Adefovir Dipivoxil Allylestrenole, Alpha Beta Arteether, Alpha Lipoic Acid, Alprazolam, Amisulpride, Amoxycillin Trihydrate, Ampicillin Trihydrate, Artemether, Atracurium Besylate, Azathioprine, Azithromycin, Balofloxacin, Bendamustine, Biotin, Bosentan, Brimonidine, Bezafibrate Mupirocin, Mycophenolate, Mycophenolate, Nadifloxacin, Naltrexone HCL and more.

Financial TrendFinancial statements 

20202021202220239.0710.0216.7826.410.000.711.081.62
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Company Update 
Announced OnApr 4, 2024
Evoq Remedies Ltd - 543500 - Clarification sought from Evoq Remedies Ltd
Evoq Remedies Ltd - 543500 - Clarification sought from Evoq Remedies Ltd
See all events